Founded Year
2004Stage
Seed | AliveTotal Raised
$1.62MLast Raised
$1.62M | 17 yrs agoAbout OMX
Developer of technology for the proteomics community serving customers in biochemistry and mass spectrometry laboratories worldwide. The company introduces a disposable as an industry standard for sample preparation in mass spectrometry-based proteomics. The company's products allow the user to pick single protein spots without the risk of contamination from a stained electrophoresis gel, digest the proteins and extract the generated peptides. The resulting sample solution is accessible for additional chromatographic separations or direct analysis by mass spectrometry.
OMX Patents
OMX has filed 42 patents.

Application Date | Grant Date | Title | Related Topics | Status |
---|---|---|---|---|
8/22/2014 | 4/2/2019 | Financial markets, Derivatives (finance), Stock market, Network protocols, Share trading | Grant |
Application Date | 8/22/2014 |
---|---|
Grant Date | 4/2/2019 |
Title | |
Related Topics | Financial markets, Derivatives (finance), Stock market, Network protocols, Share trading |
Status | Grant |
OMX Frequently Asked Questions (FAQ)
When was OMX founded?
OMX was founded in 2004.
Where is OMX's headquarters?
OMX's headquarters is located at Adlbergweg 14, Wessling.
What is OMX's latest funding round?
OMX's latest funding round is Seed.
How much did OMX raise?
OMX raised a total of $1.62M.
Who are the investors of OMX?
Investors of OMX include BayBG, Bayern Kapital and KfW.